In prostate cancer (PC), ITGB1 controls the CAV1 expression [71], and METTL3 maintains ITGB1 levels at m6A levels, which contributes to the theory of ITGB1 concentration in transcriptional modifications [59]. This evidence concerns the gene ITGB1 and pachyonychia congenita.